Table 1

Characteristics* of individuals with PMR, GCA and without either condition

Patients with PMR only (N=9776)Patients with GCA only (N=1164)Patients without PMR or GCA (N=105 504)
Sociodemographic factors
Age, years, median (IQR)73 (65–79)72 (64–79)70 (62–77)
Women, n (%)7042 (72.0)845 (72.6)76 286 (72.3)
Index of multiple deprivation, quintiles, n (%)
 1 (least deprived)1977 (20.3)211 (18.2)21 062 (20.0)
 5 (most deprived)1892 (19.4)262 (22.6)20 763 (19.8)
Ethnicity, n (%)
 White6683 (97.9)844 (96.6)62 766 (97.3)
 Asian77 (1.1)14 (1.6)768 (1.2)
 Afro-Caribbean21 (0.3)6 (0.7)448 (0.7)
 Other47 (0.7)10 (1.1)506 (0.8)
Duration of registration, years, median (IQR)14.3 (6.7–26.9)13.9 (6.4–26.1)13.4 (6.0–25.3)
Consultation rate in previous year10 (6–15)10 (6–16)5 (2–9)
Autoimmune diseases and inflammation
Other autoimmune disease, n (%)1008 (10.3)130 (11.2)7116 (6.7)
Cardiovascular risk factors
Smoking, n (%)
 Current794 (9.0)171 (16.6)10 397 (11.4)
 Former2416 (27.3)273 (26.5)22 459 (24.6)
 Never5636 (63.7)585 (56.9)58 584 (64.1)
Diabetes671 (6.9)81 (9.7)6526 (6.2)
Systolic blood pressure, mm Hg, mean (SD)144 (18.4)143 (19.7)143 (19.0)
Body mass index, kg/m2, mean (SD)26.9 (5.1)26.8 (5.6)26.7 (5.1)
Total cholesterol, mmol/L, mean (SD)5.6 (1.2)5.6 (1.2)5.6 (1.1)
HDL cholesterol, mmol/L, mean (SD)1.6 (0.5)1.5 (0.5)1.5 (0.5)
Serum creatinine, mg/L, mean (SD)87.5 (24.3)87.2 (21.8)88.2 (24.3)
Medication use in previous year
Immunosuppressant drugs, n (%)143 (1.5)593 (0.6)
Non-steroidal anti-inflammatory drugs, n (%)3080 (31.5)248 (21.3)14 240 (13.5)
Oral corticosteroids, n (%)4713 (48.2)503 (43.2)2476 (2.4)
Antiplatelet therapy, n (%)843 (8.6)123 (10.6)8787 (8.3)
Blood pressure lowering medication, n (%)4253 (43.5)477 (41.0)38 704 (36.7)
Statins, n (%)978 (10.0)102 (8.8)9230 (8.8)
  • *Missing data (%): index of multiple deprivation, 0.4%; ethnic group, 37.9%; BMI, 41.8%; systolic blood pressure, 13.0%; smoking, 13.0%; total cholesterol, 61.2%; HDL cholesterol, 71.0%; serum creatinine, 47.6%.BMI, body mass index; GCA, giant cell arteritis; HDL, high-density lipoprotein; IRR, incidence rate ratio; PMR, polymyalgia rheumatica.